Using synthetic biology to develop smarter cell therapies for cancer patients Post author: Post published:October 31, 2023 Post category:uncategorized We are embarking on an unprecedented era of therapeutic development enabled by live cellengineering. You Might Also Like NOX-1 identified as key molecular target to prolong ketamine’s antidepressant effects March 30, 2026 Sugary drinks increase hair loss risk, scientists warn August 24, 2025 MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test September 17, 2024
MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test September 17, 2024